Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

Human genes are written in long strings of three-letter units composed of four different nucleotides. These units—or ...

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr Therapeutics Ag (NASDAQ:CRSP) shares are up 16% over the past 12 months.

Genetically engineering bacteria that live on our skin could prevent frostbite and hypothermia in extreme environments ...

India has introduced national guidelines to ensure the safe and ethical use of CRISPR-based therapies, while stepping up efforts to build domestic capabilities in gene editing and advanced ...

The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.

UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T has the potential to treat many more cancers.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

A new review study explains that extremophiles have revolutionized medicine, and are invaluable allies in the fight against climate change.